Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

686 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

NCT01763866

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Glendale, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 244 locations
View Trial Details
Completed

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

NCT01375777

Conditions
Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Encinitas, California, United States
  • Research Site Inglewood, California, United States
View all 58 locations
View Trial Details
Completed

Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2

NCT01763827

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Carmichael, California, United States
View all 83 locations
View Trial Details
Completed

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

NCT01375764

Conditions
Dyslipidemias, Hypercholesterolemia, Hypercholesterolemia, Autosomal Dominant, 3, +5 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Mission Viejo, California, United States
  • Research Site Westlake Village, California, United States
  • Research Site Atlanta, Georgia, United States
View all 42 locations
View Trial Details
Completed

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

NCT04516291

Conditions
Dyslipidemias, Hyperlipidemias, Hyperlipoproteinemias, +3 more
Locations
  • Horizon Clinical Research Associates, PLLC Gilbert, Arizona, United States
  • Scottsdale Medical Imaging Research, LLC Gilbert, Arizona, United States
  • CARTI Little Rock, Arkansas, United States
  • Atria Clinical Research Little Rock, Arkansas, United States
View all 114 locations
View Trial Details
Completed

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

NCT02729025

Conditions
Behavior, Dyslipidemias, Hypercholesterolemia, Autosomal Dominant, 3, +6 more
Locations
  • Research Site Miami, Florida, United States
  • Research Site Las Vegas, Nevada, United States
  • Research Site Mooresville, North Carolina, United States
  • Research Site Philadelphia, Pennsylvania, United States
View all 15 locations
View Trial Details

Related conditions